← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 15, 2023Last known activity
Sep 4, 2025
Timeline
2010s
- Jan 1, 2016
GV20 Therapeutics— Founded
Drugs by trial phase (1 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (3)
- NCT07106827CollaboratorPhase 1Sep 4, 2025
- NCT07070518Lead sponsorPhase 1/Phase 2Jul 11, 2025
- NCT05669430Lead sponsorPhase 1Feb 15, 2023
Details
- Founded
- Shanghai, CN Jan 1, 2016
- Last known activity
- Sep 4, 2025